Prognostic value of p53 protein and MK-1 (a tumor-associated antigen) expression in gastric carcinoma

Gastric Cancer

Volumn 10, Issue 2, 2007, Pages 112-116

  Deveci, M Salih ^a   Deveci, Güzin ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Clinicopathological parameters; Gastric carcinoma; MK 1 antigen; p53 protein; Prognosis

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; PROTEIN P53;

ADULT; AGED; ANTIGEN EXPRESSION; CARDIA CANCER; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPH NODE METASTASIS; LYMPH VESSEL; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SIGNET RING CARCINOMA; STOMACH CARCINOMA; STOMACH TUMOR;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOMA, SIGNET RING CELL; CELL ADHESION MOLECULES; FEMALE; GASTRECTOMY; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34250707926     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-007-0418-7     Document Type: Conference Paper

References (25)

1. F Chang S Syrjänen K Kurvinen K Syrjänen 1993 The p53 tumor suppressor gene as a common cellular target in human carcinogenesis Am J Gastroenterol 88 174 86
2. FA Campbell HP Redmond D Bouchier-Hayes 1995 The role of tumor rejection antigens in host antitumor defense mechanisms Cancer 75 2649 55
3. F Chang S Syrjänen A Tervahauta K Syrjänen 1993 Tumourigenesis associated with the p53 tumour suppressor gene Br J Cancer 68 653 61
4. J Hurlimann EP Saraga 1994 Expression of p53 protein in gastric carcinomas. Association with histologic type and prognosis Am J Surg Pathol 18 1247 53
5. H Sasano F Date A Imatani S Asaki H Nagura 1993 Double immunostaining for c-erbB-2 and p 53 in human stomach cancer cells Hum Pathol 24 584 9
6. T Starzynska M Bromley A Ghosh PL Stern 1992 Prognostic significance of p53 overexpression in gastric and colorectal carcinoma Br J Cancer 66 558 62
7. M Fukunaga T Monden H Nakanishi M Ohue K Fukuda N Tomita 1994 Immunohistochemical study of p53 in gastric carcinoma Am J Clin Pathol 101 177 80
8. G Tamura T Kihana K Nomura M Terada T Sugimura S Hirohashi 1991 Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis Cancer Res 51 3056 8
9. HE Gabbert W Müller A Schneiders S Meier G Hommel 1995 The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma Cancer 76 720 6
10. BV Joypaul D Hopwood EL Newman S Qureshi A Grant SA Ogston 1994 The prognostic significance of the accumulation of p53 tumour suppressor gene protein in gastric adenocarcinoma Br J Cancer 69 943 6
11. BG Schneider SG Hilsenbeck CH Hensel V Pekkel CH Shelton HA Rodriguez-Martinez 1994 p53 mutations in gastric and colorectal cancers in Texas Hispanics versus Anglos Virchows Arch 424 187 93
12. J Pinto-de-Sousa F Silva L David D Leitao M Seixas A Pimenta M Cardoso-de-Oliveira 2004 Clinicopathological significance and survival influence of p53 protein expression in gastric carcinoma Histopathology 44 323 31
13. R Watanabe H Johzaki H Iwasaki M Kikuchi S Ikeda 1993 A new tumor-associated antigen defined by a monoclonal antibody directed to gastric adenocarcinoma Cancer 71 2439 47
14. Y Tomita F Arakawa T Yamamoto M Kuwahara R Watanabe H Iwasaki 2000 Molecular identification of a human carcinoma-associated glycoprotein antigen recognized by mouse monoclonal antibody FU-MK-1 Jpn J Cancer Res 91 231 8
15. SR Hamilton LA Aaltonen 2000 Pathology and genetics of tumors of the digestive system IARC Lyon 37 52
16. F Guadagni M Roselli T Amato M Cosimelli E Mannella P Perri 1991 Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma Cancer 68 2443 50
17. RR Pascal R Mesa-Tejada SJ Bennett A Garces M Fenoglio 1977 Carcinoembryonic antigen. Immunohistologic identification in invasive and intraepithelial carcinomas of lung Arch Pathol Lab Med 101 568 71
18. H Togashi PI Terasaki D Chia G Kukes H Mugishima K Kasai 1984 A monoclonal antibody, CSTO-1, against a stomach adenocarcinoma-associated antigen Cancer Res 44 3952 6
19. Y Hamada Y Nakayama M Mizoguchi S Ikeda M Kuroki H Iwasaki 2006 MK-1 expression in carcinoma of the ampulla of Vater as a predictor of improved prognosis after surgical resection Cancer Lett 7 1 6
20. A Ueno F Arakawa H Abe H Matsumoto T Kudo R Asano 2002 T-cell immunotherapy for human MK-1-expressing tumors using a fusion protein of the superantigen SEA and anti-MK-1 scFv antibody Anticancer Res 22 769 76
21. H Matsumoto S Liao F Arakawa A Ueno H Abe A Awasthi 2002 Targeting of interleukin-2 to human MK-1-expressing carcinoma by fusion with a single-chain Fv of anti-MK-1 antibody Anticancer Res 22 2001 7
22. HM Martin MI Filipe R Morris 1992 P53 expression and prognosis in gastric carcinoma Int J Cancer 50 859 62
23. M Tatematsu C Furihata T Katsuyama K Miki H Honda Y Konishi 1986 Gastric and intestinal phenotypic expressions of human signet ring cell carcinomas revealed by their biochemistry, mucin histochemistry, and ultrastructure Cancer Res 46 4866 72
24. GU Auer KM Heselmeyer RG Steinbeck E Munck-Wikland AD Zetterberg 1994 The relationship between aneuploidy and p53 overexpression during genesis of colorectal adenocarcinoma Virchows Arch 424 343 7
25. Y Kakeji D Korenaga S Tsujitani H Baba H Anai Y Maehara 1993 Gastric cancer with p53 overexpression has high potential for metastasizing to lymph nodes Br J Cancer 67 589 93